Osteosarkopeni

Hirschfeld H.P, Kinsella R, Duque G. Osteosarcopenia: Where bone, muscle, and fat collide. Osteoporos. Int. 2017; 28: 2781–90.
JA Cooper C, Rizzoli R, Reginster JY- Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int. 2019;30 (1):3-44.
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019, 48(1), 16–31.
Polito A, Barnaba E, Ciarapica D, et al. Osteosarcopenia: A Narrative Review on Clinical Studies. Int J Mol Sci. 2022, 17; 23(10): 5591. doi: 10.3390/ijms23105591
Tarantino U, Greggi C, Visconti VV et al. Sarcopenia and bone health: new acquisitions for a firm liaison. Ther Adv Musculoskelet Dis 2022, 14: 1–14.
Fatima M, Brennan-Olsen S.L, Duque G. Therapeutic approaches to osteosarcopenia: Insights for the clinician. Ther. Adv. Musculoskelet. Dis. 2019; 7;11:1759720X19867009. doi: 10.1177/1759720X19867009/
Fahimfar N, Zahedi Tajrishi F, Gharibzadeh S, et al. Prevalence of osteosarcopenia and its association with cardiovascular risk factors in Iranian older people: Bushehr Elderly Health (BEH) Program. Calcif Tissue Int 2020; 106:364-70
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: 146–56
Cruz Jentoft AJ, Sayer AA. Sarcopenia. Lancet 2019; 393:2636-46.
Duque G. Osteosarcopenia: A Geriatric Giant of the XXI Century Nutr Health Aging. 2021;25(6):716-19.
Huo YR, Suriyaarachchi P, Gomez F, et al. Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Dir Assoc 2015;16: 290-95.
Scott D, Johansson J, McMillan LB, et al. Associations of sarcopenia and its components with bone structure and incident falls in Swedish older adults. Calcif Tissue Int 2019; 105: 26-36.
Drey M, Sieber CC, Bertsch T, et al. Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res 2016; 28: 895–99.
Yoo JI, Kim H, Ha YC, et al. Osteosarcopenia in patients with hip fracture is related with high mortality. J Korean Med Sci 2017; 33(4): e27. doi: 10.3346/jkms.2018.33.e27.
Berger JM, Singh P, Khrimian L, et al. Mediation of the acute stress response by the skeleton. Cell Metab 2019; 30(5):890-902
He C, He W, Hou J, et al. Bone and muscle crosstalk in aging. Front Cell Dev Biol 2020; 10;8:585644. doi: 10.3389/fcell.2020.585644.
Deb A. How Stem Cells Turn into Bone and Fat. N. Engl. J. Med. 2019; 380:2268–70.
Chen Q, Shou P, Zheng C, et al. Fate decision of mesenchymal stem cells: Adipocytes or osteoblasts? Cell Death Differ. 2016; 23: 1128–39
Singh L, Tyagi S, Myers D, et al. Good, Bad, or Ugly: The Biological Roles of Bone Marrow Fat. Curr. Osteoporos. Rep. 2018;16: 130–37.
Correa-de-Araujo R, Addison O, Miljkovic I, et al. Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging. Front. Physiol. 2020; 11: 963. doi: 10.3389/fphys.2020.00963
Hamrick M.W, McGee-Lawrence M.E, Frechette D.M. Fatty Infiltration of Skeletal Muscle: Mechanisms and Comparisons with Bone Marrow Adiposity. Front. Endocrinol. 2016; 7: 69. doi:10.3389/fendo.2016.00069
Rivas D.A., McDonald D.J, Rice N.P, et al. Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity. Am. J. Physiol. Integr. Comp. Physiol. 2016; 310, 561–69
Schaap LA, Pluijm SMF, Deeg DJH, et al. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119(6):526.e9-17. doi: 10.1016/j.amjmed.2005.10.049.
Kim JA, Roh E, Hong SH, et al. Association of serum sclerostin levels with low skeletal muscle mass: The Korean Sarcopenic Obesity Study (KSOS). Bone. 2019;128:115053. doi:10.1016/j.bone.2019.115053
Chung PL, Zhou S, Eslami B, et al. Effect of age on regulation of human osteoclast differentiation. J Cell Biochem. 2014;115:1412-19
Lindsey R.C, Mohan S. Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Mol. Cell. Endocrinol. 2015; 432: 44–55.
Ferrucci L, Baroni M, Ranchelli A, et al. Interaction between Bone and Muscle in Older Persons with Mobility Limitations. Curr. Pharm. Des. 2014; 20: 3178–97.
Daly RM. Exercise and nutritional approaches to prevent frail bones, falls and fractures: an update. Climacteric. 2017; 20:119–21
Bowser M, Herberg S, Arounleut P, et al. Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells. Exp Gerontol 2013; 48:290–97
Renoud A, Ecochard R, Marchand F, et al. Predictive parameters of accelerated muscle loss in men-MINOS study. Am J Med 2014; 127: 554–61.
Sepúlveda-Loyola W, Phu S, Hassan E.B, et al. The joint occur-rence of osteoporosis and sarcopenia (osteosarcopenia): Definitions and characteristics. J. Am. Med. Dir. Assoc. 2020; 21: 220–25
World Health Organization. Prevention and Management of Osteoporosis; WHO Technical Report Series n. 921; World Health Organization: Geneva, Switzerland, 2003. https://apps.who.int/iris/handle/10665/42841 (Accessed: 22th January 2023)
Boutin RD, Yao L, Canter RJ, et al. Sarcopenia: Current concepts and imaging implications. AJR 2015; 205(3): 255-66.
Kirazlı Y. Sarkopenide Görüntüleme Yöntemleri. Eds, Kutsal YG. Osteosarkopeni. Ankara: Türkiye Osteoporoz Derneği; 2022. pp 49-59
Schweitzer L, Geisler C, Pourhassan M et al. What is the best reference site for a single MRI slice to assess whole-body skeletal muscle and adipose tissue volumes in healthy adults? Am J Clin Nutr 2015; 102: 58–65.
Petak S, Barbu CG, Yu EW, et al. The official positions of the International Society for Clinical Densitometry: body composition analysis reporting. J Clin Densitom 2013; 16: 508-19.
Suetta C, Haddock B, Alcazar J, et al. The Copenhagen Sarcopenia Study: lean mass, strength, power, and physical function in a Danish cohort aged 20-93 years. J Cachexia Sarcopenia Muscle 2019; 10: 1316-29.
Peppa M, Stefanaki C, Papaefstathiou A, et al. Bioimpedance analysis vs. DEXA as a screening tool for osteosarcopenia in lean, overweight and obese Caucasian postmenopausal females. Hormones 2017; 16: 181–93.
Ticinesi A, Meschi T, Narici MV et al. Muscle ultrasound and sarcopenia in older individuals: a clinical perspective. J Am Med Dir Assoc 2017; 18: 290–300.
Hamad B, Basaran S, Benlidayi I.C. Osteosarcopenia among postmenopausal women and handgrip strength as a practical method for predicting the risk. Aging 2019, 32, 1923–30..
Fathi M, Heshmat R, Ebrahimi M, et al. Association between biomarkers of bone health and osteosarcopenia among Iranian older people: The Bushehr Elderly Health (BEH) program. BMC Geriatr. 2021; 21: 654. https://doi.org/10.1186/s12877-021-02608-w
Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2002; 77: 453–68.
Hassan EB, Duque G. Osteosarcopenia: a new geriatric syndrome. Aust Fam Physician 2017; 46: 849–53.
Reginster JY, Beaudart C, Buckinx F, et al. Osteoporosis and sarcopenia: two diseases or one? Curr Opin Clin Nutr Metab Care 2016; 19(1): 31-36.
Buehring B and Binkley N. Myostatin–the holy grail for muscle, bone, and fat? Curr Osteoporos Rep 2013; 11: 407–14.
Bermeo S, Gunaratnam K and Duque G. Fat and bone interactions. Curr Osteoporos Rep 2014; 12: 235–42.
Gomez F, Curcio C.L, Brennan-Olsen S.L, et al. Effects of the falls and frac-tures clinic as an integrated multidisciplinary model of care in Australia: A pre–post study. BMJ Open 2019; 29; 9(7): e027013. doi: 10.1136/bmjopen-2018-027013.
Chew J, Yeo A, Yew S, et al. Nutrition mediates the relationship between osteosarcopenia and frailty: a pathway analysis. Nutrients. 2020;12(10):2957 doi: 10.3390/nu12102957.
Can B, Şanlıer N. Osteosarkopenide Beslenme Yaklaşımları: Geleneksel Derleme. Turkiye Klinikleri J Health Sci 2022; 7(4):1216-25
Mu-oz-garach a, garcía-Fontana B, Mu-oz-Torres M. Nutrients and dietary patterns related to osteoporosis. Nutrients. 2020;12(7):1986 doi: 10.3390/nu12071986.
Eley H.L; Russell ST.; Tisdale M.J. Mechanism of Attenuation of Muscle Protein Degradation Induced by Tumor Necrosis Factor-α and Angiotensin II by β-Hydroxy-β-Methylbutyrate. Am J Physiol Endocrinol Metab. 2008; 295: 1417–26
Papadopoulou, S.K. Sarcopenia: A Contemporary Health Problem among Older Adult Populations. Nutrients 2020; 12(5): 1293. doi: 10.3390/nu12051293.
Candow DG, Forbes SC, Chilibeck PD, et al. Effectiveness of creatine supplementation on aging muscle and bone: focus on falls prevention and inflammation. J Clin Med 2019; 8: 488. doi:10.3390/jcm8040488
Kutsal YG, Ozdemir O, Sarıdoğan M, et al. Osteosarkopeni: Klinik Perspektif. Turk J Osteoporos 2020; 26: 47-57
Bruyere O, Cavalier E, Reginster JY. Vitamin D and Osteosarcopenia: an ubdate from epidemiological studies. Curr Opin Clin Nutr Metab Care 2017; 20 (6):498–50
Landi F, Cesari M, Calvani R et al. The “Sarcopenia and Physical FRailty IN Older People: Multi-ComponenT Treatment Strategies” (SPRINTT) Randomized Controlled Trial: Design and Methods. Aging Clin. Exp. Res. 2017; 29: 89–100
Cruz-jentoft AJ, Landi F, schneider SM, et al. prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International sarcopenia Initiative (EWgsOp and IWgs). Age ageing. 2014;43(6):7
Lavado-garcía J, Roncero-Martin R, Moran jM, et al. Long-chain omega-3 polyunsaturated fatty acid dietary intake is positively associated with bone mineral density in normal and osteopenic spanish women. pLos One. 2018;13(1): e0190539. https://doi.org/10.1371/journal.pone.0190539
Sadeghi O, Djafarian K, Ghorabi S, et al. Dietary intake of fish, n-3 polyunsaturated fatty acids and risk of hip fracture: a systematic review and meta-analysis on observational studies. Crit Rev Food sci Nutr. 2019;59(8):1320-33
Frontera WR. Rehabilitation of Older Adults with Sarcopenia: From Cell to Functioning. Prog Rehabil Med 2022; 7: 20220044 doi: 10.2490/prm.20220044.
O’Bryan SJ, Giuliano C, Woessner MN, et al. Progressive resistance training for concomitant increases in muscle strength and bone mineral density in older adults: a systematic review and meta-analysis. Sports Med 2022;52:1939– 60
Balachandran AT, Steele J, Angielczyk D, et al. Comparison of power training vs traditional strength training on physical function in older adults: a systematic review and meta-analysis. JAMA Net Open 2022;5:e2211623. doi:10.1001/jamanetworkopen.2022.11623
Bernabei R, Landi F, Calvani R, et al. Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project). BMJ 2022;377:e068788. doi:10.1136/bmj-2021-068788.
Yoo, S.-Z.; No, M.-H.; Heo, J.-W.; et al. Role of Exercise in Age-Related Sarcopenia. J Exerc Rehabil. 2018, 14, 551–58.
Paillard, T. Relationship between Muscle Function, Muscle Typology and Postural Performance According to Different Postural Conditions in Young and Older Adults. Front Physiol. 2017; 8: 585. doi: 10.3389/fphys.2017.00585.
Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int 2005; 16: 155–162. 22
Kanis JA, Johansson H, Johnell O, et al. Alcohol intake as a risk factor for fracture. Osteoporos Int 2005; 16: 737–42.
Miedany YE, Gaafary ME, Toth M, et al. Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia. Clin Rheumatol 2021; 40: 4225–32.
Bonnet N, Bourgoin L, Biver E, et al. RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest 2019; 129: 3214–23.
Narayanan R, Coss C, Dalton JT. Development of selective androgen receptor modulators (SARMs). Mol Cell Endocrinol 2018; 465: 134–42.
Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a doubleblind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle 2011; 2: 153–61
Bian A, Ma Y, Zhou X, et al. Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet Disord 2020; 21: 214. https://doi.org/10.1186/s12891-020-03236-y
Sullivan DH, Carter WJ, Warr WR, et al. Side effects resulting from the use of growth hormone and insulin-like growth factor-I as combined therapy to frail elderly patients. J Gerontol A Biol Sci Med Sci 1998; 53: 183–87
Robbins PD, Jurk D, Khosla S, et al. Senolytic drugs: reducing senescent cell viability to extend health span. Annu Rev Pharmacol Toxicol 2021;61:779–803. doi:10.1146/annurevpharmtox-050120-105018.
X u M, Pirtskhalava T, Farr JN, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med 2018; 24: 1246–56. doi:10.1038/s41591-018-0092-9
Hickson LJ, Langhi Prata LG, Bobart SA, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine 2019; 47:446–56. doi:10.1016/j. Ebiom.2019.08.069.
Yamanaka S: Pluripotent stem cell-based cell therapy – promise and challenges. Cell Stem Cell 2020; 27: 523– 31. doi:10.1016/j.stem.2020.09.014.
Cosgrove BD, Gilbert PM, Porpiglia E, et al. Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat Med 2014; 20: 255–64. doi:10.1038/nm.3464.
Pratt J, Boreham C, Ennis S, et al. Genetic associations with aging muscle: a systematic review. Cells 2019; 9: 12. doi:10.3390/cells9010012.
Khanal P, He L, Stebbings G, et al. Prevalence and association of single nucleotide polymorphisms with sarcopenia in older women depends on definition. Sci Rep 2020;10:2913. doi:10.1038/ s41598-020-59722-9.